Speaker
Founder & Former Chief Scientific Officer, Arrakis Therapeutics Inc.
Jennifer Petter, Founder & Former Chief Scientific Officer at Arrakis Therapeutics Inc., is speaking at 9th RNA-Targeted Drug Discovery & Development Summit (Boston, United States of America, 10–12 Nov 2026) in the session “Panel Discussion: Target-Focused vs High-Throughput Approaches for Discovering Therapeutically Effective RNA-Targeting Small Molecules”.
10–12 Nov 2026Boston, United States of America
Associate Director, Early Discovery Chemistry, PTC Therapeutics
Professor & Associate Chair of Graduate Affairs, University of Colorado Boulder
Chief Scientific Officer, Dewpoint Therapeutics
Head of Cancer Biology, EPICS Therapeutics
Senior Principal Scientist & Research Fellow, Pfizer
Head of Small Molecules Medicinal Chemistry, Sanofi
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Jennifer Petter, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].